Expert Perspectives on Advances in the Management of C. difficile - Episode 13

C. Difficile Treatment: Bezlotoxumab

The rationale for using bezlotoxumab as treatment for certain patients with C. difficile infections and current limitations that are impacting its use in clinical practice.